Literature DB >> 21264942

Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of FP-CIT single photon emission computed tomography.

Carsten Eggers1, Deniz Kahraman, Gereon R Fink, Matthias Schmidt, Lars Timmermann.   

Abstract

OBJECTIVE: To elucidate whether Parkinson's disease subtypes show a different pattern of Iodine-123 fluoropropyl-;carbomethoxy-3 β-(FP-CIT) single photon emission computed tomography (SPECT) binding in accordance with neuropathological findings.
METHODS: We analyzed a database of consecutive patients with FP-CIT scan (n = 190) over a 3-year period and identified 122 patients (50 women, 72 men, mean age 62 ± 11.1 years) with a diagnosis of idiopathic Parkinson's disease. Patient's characteristics and FP-CIT scan results were analyzed and compared for the subgroups tremor-dominant versus akinetic-rigid and equivalent type of Parkinson's disease.
RESULTS: The analysis of all Parkinson's disease patients showed a significant difference between the FP-CIT uptake in the subgroups tremor-dominant and akinetic-rigid. After matching these samples for age, disease duration, disease severity (Hoehn & Yahr grade, Unified Parkinson's Disease Rating Scale score), and levodopa-equivalent dose, these findings were balanced between both groups (n = 23/23) without a significant difference (P > 0.05). However, there was a clear, significant association of visually analyzed shapes of the striatum in FP-CIT SPECT and clinical Parkinson's disease subtype.
CONCLUSION: These results confirm neuropathological models for a reduced dopaminergic projection to the dorsal putamen in akinetic-rigid patients as well as the lateral putamen and caudate nucleus in tremor-dominant patients in vivo.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21264942     DOI: 10.1002/mds.23468

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  54 in total

1.  Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease.

Authors:  Deniz Kahraman; Carsten Eggers; Harald Schicha; Lars Timmermann; Matthias Schmidt
Journal:  J Neurol       Date:  2011-07-13       Impact factor: 4.849

2.  Morphologic changes in the mesolimbic pathway in Parkinson's disease motor subtypes.

Authors:  Eric M Nyberg; Jody Tanabe; Justin M Honce; Theodore Krmpotich; Erika Shelton; Jessica Hedeman; Brian D Berman
Journal:  Parkinsonism Relat Disord       Date:  2015-03-13       Impact factor: 4.891

3.  Levodopa changes brain motor network function during ankle movements in Parkinson's disease.

Authors:  Petra Schwingenschuh; Petra Katschnig; Margit Jehna; Mariella Koegl-Wallner; Stephan Seiler; Karoline Wenzel; Stefan Ropele; Christian Langkammer; Thomas Gattringer; Martin Svehlík; Erwin Ott; Franz Fazekas; Reinhold Schmidt; Christian Enzinger
Journal:  J Neural Transm (Vienna)       Date:  2012-09-19       Impact factor: 3.575

4.  Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease.

Authors:  Marcello Moccia; Sabina Pappatà; Marina Picillo; Roberto Erro; Anna Rita Daniela Coda; Katia Longo; Carmine Vitale; Marianna Amboni; Arturo Brunetti; Giuseppe Capo; Marco Salvatore; Paolo Barone; Maria Teresa Pellecchia
Journal:  J Neurol       Date:  2014-08-14       Impact factor: 4.849

5.  Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson's disease.

Authors:  Ilknur Telkes; Ashwin Viswanathan; Joohi Jimenez-Shahed; Aviva Abosch; Musa Ozturk; Akshay Gupte; Joseph Jankovic; Nuri F Ince
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-21       Impact factor: 11.205

Review 6.  Dyskinesias and levodopa therapy: why wait?

Authors:  Michele Matarazzo; Alexandra Perez-Soriano; A Jon Stoessl
Journal:  J Neural Transm (Vienna)       Date:  2018-02-10       Impact factor: 3.575

7.  Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson's disease.

Authors:  Valtteri Kaasinen; Maija Kinos; Juho Joutsa; Marko Seppänen; Tommi Noponen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-28       Impact factor: 9.236

Review 8.  Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Authors:  J A Obeso; M Stamelou; C G Goetz; W Poewe; A E Lang; D Weintraub; D Burn; G M Halliday; E Bezard; S Przedborski; S Lehericy; D J Brooks; J C Rothwell; M Hallett; M R DeLong; C Marras; C M Tanner; G W Ross; J W Langston; C Klein; V Bonifati; J Jankovic; A M Lozano; G Deuschl; H Bergman; E Tolosa; M Rodriguez-Violante; S Fahn; R B Postuma; D Berg; K Marek; D G Standaert; D J Surmeier; C W Olanow; J H Kordower; P Calabresi; A H V Schapira; A J Stoessl
Journal:  Mov Disord       Date:  2017-09       Impact factor: 10.338

9.  Default-mode network connectivity in cognitively unimpaired drug-naïve patients with rigidity-dominant Parkinson's disease.

Authors:  Yanbing Hou; Chunyan Luo; Jing Yang; Ruwei Ou; Wanglin Liu; Wei Song; Qiyong Gong; Huifang Shang
Journal:  J Neurol       Date:  2016-11-15       Impact factor: 4.849

10.  The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage.

Authors:  Han Soo Yoo; Seok Jong Chung; Soo-Jong Kim; Jung Su Oh; Jae Seung Kim; Byoung Seok Ye; Young Ho Sohn; Phil Hyu Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.